Champions Oncology, Inc.
CSBR
$7.63
$0.222.97%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.70M | 6.43M | -598.00K | -3.40M | -7.28M |
| Total Depreciation and Amortization | 1.64M | 1.70M | 1.79M | 1.87M | 1.87M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.67M | 2.15M | 2.39M | 2.72M | 3.10M |
| Change in Net Operating Assets | -621.00K | -11.58M | -6.28M | -3.03M | -3.82M |
| Cash from Operations | 7.39M | -1.30M | -2.71M | -1.84M | -6.14M |
| Capital Expenditure | -389.00K | -133.00K | -183.00K | -168.00K | -836.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -389.00K | -133.00K | -183.00K | -168.00K | -836.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -150.00K | -150.00K | -146.00K | -183.00K | -146.00K |
| Issuance of Common Stock | 320.00K | 315.00K | 277.00K | 241.00K | 253.00K |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -32.00K | -634.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 170.00K | 165.00K | 131.00K | 26.00K | -527.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.17M | -1.27M | -2.76M | -1.98M | -7.50M |